Search Results for “H19-423_V1.0 Latest Test Testking 🍀 H19-423_V1.0 Practical Information 📄 H19-423_V1.0 Test Price 🕔 Go to website ☀ www.pdfvce.com ️☀️ open and search for ➠ H19-423_V1.0 🠰 to download for free 🎤H19-423_V1.0 Download Pdf” – Page 29

Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the icatibant outcome survey

279

Aberer, W.+, Maurer, M. Bouillet, L., Zanichelli, A., Caballero, T., Longhurst, H. J., Perrin, A., and Andresen, I.: Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the icatibant outcome survey. Allerg. Asthma Clin. Immunol. 2017: 13; 31. IF: 2.05

How not to miss autoinflammatory diseases masquerading as urticaria

142

Krause, K., Grattan, C. E., Bindslev-Jensen, C., Gattorno, M., Kallinich, T., de Koning, H. D., Lachmann, H. J., Lipsker, D., Navarini, A. A., Simon, A., Traidl-Hoffmann, C., and Maurer, M.+: How not to miss autoinflammatory diseases masquerading as urticaria. Allergy 2012: 67; 1465-1474. IF: 5.88

o.142

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU

318

Sussman, G.+, Abuzakouk, M., Bérard, F., Canonica, W., Oude Elberink, H., Giménez-Arnau, A., Grattan, C., Hollis, K., Hunter, S., Knulst, A., Lacour, J. P., Lynde, C., Marsland, A., McBride, D., Maurer, M. Nakonechna, A., Ortiz de Frutos, J., Reynolds, M., Sweeney, C., Tian, H., Weller, K., Wolin, D., and Balp, M. M.: Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU. Allergy 2018: 73; 1724-1734. IF: 6.77

152	Türk, M., Carneiro-Leão, L., Kolkhir, P., Bonnekoh, H., Buttgereit, T., and Maurer, M.+: How to treat patients with chronic spontaneous urticaria with omalizumab: questions and answers. J. Allergy Clin. Immunol. Pract. 2020: 8; 115-124. IF: 8.86

r.152

64.	Krause, K., Metz, M., Makris, M., Zuberbier, T., and Maurer, M.: The role of Interleukin-1 in allergy-related disorders. Curr. Opin. Allergy Clin. Immunol. 2012: 12; 477-484. IF: 3.39

Who is really in control of skin immunity under physiological circumstances – lymphocytes, dendritic cells or keratinocytes?

14.

Schröder, J. M., Reich, K., Kabashima, K., Liu, F. T., Romani, N., Metz, M., Kerstan, A., Lee, P. H. A., Loser, K., Schön, M. P., Maurer, M., Stoitzner, P., Beissert, S., Tokura, Y., and Gallo, R. L.: Who is really in control of skin immunity under physiological circumstances – lymphocytes, dendritic cells or keratinocytes? Exp. Dermatol. 2006: 15; 913-929. IF: 2.45

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

204

Saini, S. S., Bindslev-Jensen, C., Maurer, M. Grob, J.-J., Baskan, E. B., Bradley, M. S., Canvin, J., Rahmaoui, A., Georgiou, P., Alpan, O., Spector, S., and Rosén, K.+: Efficacy and safety of Omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1-antihistamines: A randomized, placebo-controlled study. J. Invest. Dermatol. 2015: 135; 67-75. IF: 6.91

107	Altrichter, S., Peter, H.-J., Pisarevskaja, D., Metz, M., Martus, P., and Maurer, M.+: IgE mediated autoallergy against thyroid peroxidase – a novel pathomechanism of chronic spontaneous urticaria? PLoS ONE 2011: 6; e14794. IF: 4.09

o.107

Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase

114

Maurer, M.+ Altrichter, S., Bieber, T., Biedermann, T., Bräutigam, M., Seyfried, S, Brehler, R., Grabbe, J., Hunzelmann, N., Jakob, T., Jung, A., Kleine-Tebbe, J., Mempel, M., Meurer, M., Reich, K., Ruëff, F., Sengupta, K., Sieder, C., Simon, J. C., Wedi, B., Zuberbier, T., Mahler, V., and Staubach, P.: Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyreoperoxidase. J. Allergy Clin. Immunol. 2011: 128; 202-209. IF: 11.00

o.114

278	Caballero, T. + Aberer, W., Longhurst, H. J., Maurer, M. Zanichelli, A., Perrin, A., Bouillet, L., and Andresen, I.: The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries. J. Eur. Acad. Dermatol. Venereol. 2017: 31; 1214-1222. IF: 4.29

Results